Home › Funds › Valiant Capital Management, L.P. › GRDN

Valiant Capital Management, L.P. position in GRDN

GUARDIAN PHARMACY SVCS INC · Consumer Staples

Valiant Capital Management, L.P. reported holding 1,186,658 shares of GRDN (GUARDIAN PHARMACY SVCS INC) in its Q2 2026 13F filing — a position valued at US$49.7M, representing 2.80% of its reported portfolio and ranking #9 among its reported holdings. Valiant Capital Management, L.P. has disclosed GRDN holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)1.19M sh
Reported value held$49.69M
Portfolio Weight2.80%
First reportedQ3 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Valiant Capital Management, L.P.'s GRDN position evolved

Valiant Capital Management, L.P. first disclosed a stake in GRDN in Q3 2025 at 1,064,722 shares (US$27.9M). The position peaked in Q2 2026 at 1,186,658 shares, worth US$49.7M. Across 4 filings, Valiant Capital Management, L.P. increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 1,186,658 shares valued at US$49.7M.

Quarter by quarter

QuarterSharesValueChange
Q3 2025 1.06M $27.93M New
Q4 2025 1.23M $37.08M Add
Q1 2026 1.19M $44.69M Reduce
Q2 2026 1.19M $49.69M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GRDN and 13F data

GRDN (GUARDIAN PHARMACY SVCS INC) is a Consumer Staples company. 71 other funds we track also report a position in GRDN — the largest reported positions include BOONE CAPITAL MANAGEMENT LLC (US$29.8M), Aristotle Capital Boston, LLC (US$17.7M), Lisanti Capital Growth, LLC (US$6.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GRDN

All GRDN fund holders →

FAQ

How long has Valiant Capital Management, L.P. held GRDN?

Valiant Capital Management, L.P. has disclosed GRDN holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is Valiant Capital Management, L.P.'s current position in GRDN?

As of Q2 2026, Valiant Capital Management, L.P. holds 1.19M shares of GRDN (GUARDIAN PHARMACY SVCS INC), valued at $49.69M, representing 2.80% of its reported portfolio and ranking #9.

Has Valiant Capital Management, L.P. been buying or selling GRDN?

In the latest 13F filing (Q2 2026), Valiant Capital Management, L.P. held unchanged its position in GRDN. The position peaked in Q2 2026 at 1.19M shares.

Which other funds hold GRDN?

Other major institutional holders of GRDN include BOONE CAPITAL MANAGEMENT LLC, Aristotle Capital Boston, LLC, Lisanti Capital Growth, LLC, among 71 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.